Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term child health outcomes after in utero exposure to IBD medication
NL-OMON19876Recruiting
- Sponsor
- Erasmus MC
- Start
- Mar 2010
- Countries
- 1
01
Overview
Open-label, single-arm trial in inflammatory bowel disease (IBD), sponsored by Erasmus MC. Primary endpoints: Growth, Infections in first 5 years of life requiring antibiotics and 3 more. Started Mar 2010; status: recruiting.
02
Conditions
inflammatory bowel disease (IBD)
Beyond the preview
Go deeper on NL-OMON19876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON19876.